Jane Huang, CMO, Hematology at BeiGene, Ltd. (BGNE), sold 1,206 shares at $351.55 ($424K) on 2021-06-07, disclosed to the SEC on 2021-06-09.
Seasonal sale ($424k) by CMO, Hematology — this insider has traded BGNE in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $351.55 | 603 | $212K | 50.0% |
| 2 | $351.55 | 603 | $212K | 50.0% |
| Total | $351.55 avg | 1,206 | $424K | 100% |
| Filing → |
| BGNE | SELL | 2021-12-02 | $755K | — | Filing → |
| BGNE | SELL | 2021-11-19 | $572K | — | Filing → |
| BGNE | SELL | 2021-10-21 | $559K | — | Filing → |